Related-Party Transactions

On November 16, 2015, UCAP entered into a subordinated note receivable agreement with UCI, a 48.9% owned equity method investee (see Note 5), in the amount of $5.0 million. On June 28, 2018 and November 28, 2018, UCAP entered into two additional subordinated note receivable agreements with UCI in the amount of $2.5 million and $5.0 million, respectively (see Note 6).

During the three months ended March 31, 2020 and 2019, NMM earned approximately $4.2 million and $3.2 million, respectively, in management fees from LMA, which is accounted for under the equity method based on 25% equity ownership interest held by APC in LMA’s IPA line of business (see Note 5).

During the three months ended March 31, 2020 and 2019, APC paid approximately $0.6 million and $0.7 million, respectively, to PMIOC for provider services, which is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 5).

During the three months ended March 31, 2020 and 2019, APC paid approximately $1.8 million and $2.0 million, respectively, to DMG for provider services, which is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 5).

During the three months ended March 31, 2020 and 2019, APC paid approximately $39,800 and $92,000, respectively, to Advanced Diagnostic Surgery Center for services as a provider. Advanced Diagnostic Surgery Center shares common ownership with certain board members of APC.

During the three months ended March 31, 2020 and 2019, APC paid an aggregate of approximately $7.3 million and $9.3 million, respectively, to shareholders of APC for provider services, which include approximately $1.7 million and $3.3 million, respectively, to shareholders who are also officers of APC.

During the three months ended March 31, 2020 and 2019, NMM paid approximately $0.3 million, respectively, to Medical Property Partners (“MPP”) for an office lease. MPP shares common ownership with certain board members of NMM.

During the three months ended March 31, 2020, NMM paid approximately $0.4 million, respectively, to One MSO, Inc. ("One MSO") for an office lease. One MSO shares common ownership with certain board members of NMM. As of March 31, 2020, the Company had $10.8 million of ROU assets and lease liabilities, respectively, related to its office lease with One MSO to be amortized over the remaining life of the lease.

During the three months ended March 31, 2020 and 2019, the Company paid approximately $0.1 million, respectively, to Critical Quality Management Corporation (“CQMC”) for an office lease. CQMC shares common ownership with certain board members of APC.

During the three months ended March 31, 2020 and 2019, SCHC paid approximately $0.1 million, respectively, to Numen, LLC (“Numen”) for an office lease. Numen is owned by a shareholder of APC.

The Company has agreements with HSMSO, Aurion Corporation (“Aurion”), and AHMC Healthcare (“AHMC”) for services provided to the Company. One of the Company’s board members is an officer of AHMC, HSMSO and Aurion. Aurion is also partially owned by one of the Company’s board members. The following table sets forth fees incurred and income earned related to AHMC, HSMSO and Aurion (in thousands):



	Three Months Ended March 31,
	2020			2019
AHMC – Risk pool and capitation	$	11,999		$	11,600
HSMSO – Management fees, net	(132		)	(650		)
Aurion – Management fees	(75		)	(100		)

Net total	$	11,792		$	10,850

The Company and AHMC have a risk sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. During the three months ended March 31, 2020 and 2019, the Company has recognized risk pool revenue under this agreement of $12.0 million and $10.1 million, respectively, for which $47.2 million and $40.4 million remain outstanding as of March 31, 2020 and December 31, 2019, respectively.

During the quarter ended March 31, 2020, NMM paid approximately $26,600 to an Apollo board member for consulting services.

In addition, affiliates wholly owned by the Company’s officers, including the Company's Co-CEOs, Dr. Sim and Dr. Lam, are reported in the accompanying consolidated statements of income on a consolidated basis, together with the Company’s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company’s subsidiaries as related-party transactions.

For equity method investments, loans receivable and line of credits from related parties, see Notes 5, 6 and 9, respectively.